Pharma Congress Production and Technology in Düsseldorf, Germany, on 22 and 23 March 2011.  
 

Speakers

The following speakers from leading pharmaceutical companies and from authorities will be lecturing at the Pharma Congress 2012:

  • Nigel Bates, Pfizer Ltd, Great Abington, Cambridge, UK
    Head of the Engineering Sciences Group within the Devices Centre of Emphasis, based in Cambridge UK.
  • Edgar Bauer, Bausch + Ströbel Maschinenfabrik Ilshofen GmbH + Co. KG, Ilshofen
    Mr Bauer (Area Sales Manager) has been in charge of the French market in the Sales Department since 2000.
  • Dirk Beer, Nycomed GmbH, Singen, Germany
    Mr Beer is responsible for assessment of suppliers for packaging materials including auditing and handling of complaints.
  • Dr Andrea Behrenswerth, Gerresheimer Bünde GmbH, Bünde, Germany
    Head of Quality Assurance within Gerresheimer Bünde.
  • Dr Klaus Buchweitz, Sandoz AG, Holzkirchen, Germany
    Since 2011 head of Third Party Management.
  • Gerald Bürkle, Vetter Pharma-Fertigung GmbH & Co. KG, Ravensburg, Germany
    Director Pharmaceutical Production.
  • Philippe Cappuyns, Janssen Pharmaceutica
    Part of Global Technical Services within Janssen Supply Chain responsible for assessment of innovative technologies and the introduction of QbD in development and production.
  • Dr Olivier Chancel, Merial, Toulouse, France
    Currently Head of Pharmaceutical Support in Merial.
  • Piet Christiaens, Toxikon Europe NV, Heverlee, Belgium
    Mr Christiaens holds the position of Scientific Director.
  • Peter Cornelis, Toxikon Europe NV, Heverlee, Belgium
    Mr Cornelis is Department Supervisor of the Microbiology and In-vitro Toxicology Department.
  • William Dierick, TERUMO EUROPE NV, Leuven, Belgium
    William Dierick is Business Development Manager – Global Pharmaceutical Solutions of TERUMO.
  • Christian Doriath, Lilly France SAS, Fegersheim, France
    At Lilly he is currently working as a Global Network Expert for the whole isolator’s technology.
  • Dr Peter Gassmann, Cilag AG, Schaffhausen, Switzerland
    He joined the QA/QC department and is currently Director of Quality Operations and Tech Support.
  • Jens Gemmecker, OPTIMA GROUP pharma GmbH, Mornshausen, Germany
    Sales manager at OPTIMA GROUP pharma, facility Mornshausen.
  • Angela Gessler, Skan AG, Allschwil, Switzerland
    At Skan AG she supervises a laboratory for H2O2 decontamination studies as well as H2O2 low concentration measurements.
  • Leopold Gruber, SBM Schoeller Bleckmann Medizintechnik Ges.m.B., Ternitz, Austria
    Mr Gruber was active from 1974 till the end of 2010 in the area of the design and sales in leading functions.
  • Dr Roland Guinet, Consultant Regulatory Compliance Sites and Processes.
    From 2002-2011 GMP Inspector at AFSSaPS (French Agency for the Safety of Health Products).
  • Henry Huang, AstraZeneca
    Senior Formulation Scientist.
  • Dr Renaud Janssen, Helvoet Pharma Belgium, Alken, Belgium
    He is currently Global Director of Scientific Affairs for Helvoet Pharma worldwide.
  • Dr Timo Krebsbach, Labor L+S AG, Bad Bocklet, Germany
    Dr Krebsbach is head of the sterility testing department and responsible for sterility tests performed in a cleanroom as well as in isolators.
  • Jens Kubischik, Pall GmbH, Dreieich, Germany
    Mr Kubischik is project manager for single-use-disposables in Europe.
  • Sigrid Lieb, Vetter Pharma-Fertigung GmbH & Co, KG, Ravensburg
    Sigrid Lieb is project manager for internal and investment projects.
  • Dr Santiago Llovera, Boehringer Ingelheim Espana S.A., Sant Cugat des Vallès, Spain
    Dr Llovera is Injectable Manufacturing Manager.
  • Dr Jörg Lümkemann, F. Hoffmann-La Roche AG, Basel, Switzerland
    He is in the development of parenterals and in charge of the implementation of new technologies in this area.
  • Jack Lysfjord, Jack Lysfjord Consulting LLC, Minnetonka, US
    Mr Lysfjord is Consultant in the field of Strategic Aseptic Processing.
  • Dr Jean-Denis Mallet, SNC Lavalin, Ivry-sur-Seine, France
    Director Pharma Europe, formerly Head of the French Pharmaceutical Inspection Department (AFSSAPS).
  • Gert Moelgaard, NNE Pharmaplan, Søborg, Denmark
    Gert Moelgaard is Vice President for Innovation & Business Development in NNE Pharmaplan.
  • Alessandro Morandotti, Nuova OMPI, Piombino Dese, Padova, Italy
    Alessandro Morandotti is leading the development of new sterile products within the R&D organisation.
  • Alicia Mozzachio, FDA, USA
    Director Regulatory, Office of Manufacturing and Product Quality (OMPQ).
  • Dr Daniel Müller, Regierungspräsidium Tübingen, Germany
    Dr Müller is GMP-Inspector with focus on biotechnological active ingredients and sterile drug products.
  • Dr Wenzel Novak, groninger & co. gmbH, Crailsheim, Germany
    Dr Novak is responsible for pharmaceutical research and development.
  • Franck Pavan, Pierre FABRE Medicament Production, Idron, France
    Business Development Manager focused on Strategy and Development of contract manufacturing.
  • Matthias Poslovski, OPTIMA GROUP pharma GmbH, Schwäbisch Hall, Germany
    Director Technical Sales, responsible for US and South American markets.
  • Dr Ingo Presser, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
    Dr Presser is in charge of the clinical trail supply and process transfer unit with the Process Science Department.
  • Dr Heino Prinz, Wilco AG, Wohlen, Switzerland
    Dr Prinz is in charge of research and development.
  • Dr Bernd Renger, Bernd Renger Pharma Consulting GmbH, Radolfzel, Germany
    He is running his own consultancy business and was prior Director of QC at Vetter Pharma-Fertigung.
  • Harald Römer, Notter GmbH
    Mr Römer is consultant and also working for Notter in the field of application technology.
  • Dr Uwe Rothhaar, Schott AG, Mainz, Germany
    He primarily focuses on the chemical resistance and mechanical stability of pharmaceutical primary packing.
  • Hartmut Schaz, NNE Pharmaplan GmbH, Bad Homburg, Germany
    He is Senior Expert for Small Volume Parenteral Products and Director of the Board of NNE Pharmaplan India.
  • Dr Hans-Georg Schindler, Seidenader Vision GmbH, Markt Schwaben, Germany
    Since 2006 responsible for development and integration of innovative inspection methods.
  • Dr Thomas Scholzen,F. Hoffmann-La Roche AG, Basel, Switzerland
    Quality Management of primary packaging materials at Roche Global Supplier Quality Management.
  • Dr Harald Stahl, GEA Pharma Systems
    Harald Stahl presently is Senior Pharmaceutical Technologist. He has published more than 20 papers on various aspects of pharmaceutical production.
  • Christoph von Stenglin, OPTIMA GROUP pharma GmbH, Radolfszell, Germany
    Managing Director.
  • Dr Alexander Sterchi, F. Hoffmann-La Roche AG, Basel
    Since 2008 he is heading Logistics, Services & Infrastructure.
  • Klaus Ullherr, Robert Bosch GmbH, Crailsheim, Germany
    Mr Ullherr is Product Manager for the business fields syringes and cartridges.
  • Benoît Verjans, Aseptic Technologies S.A., Les Isnes, Belgium
    He is currently Commercial Director of Aseptic Technologies, responsible of developing the sales of the closed vial technology worldwide.
  • Dr Christian Vogt, Novartis Pharma Stein AG, Stein/Basle, Switzerland
    Dr Vogt is responsible for sterility testing and microbiological QA and QC.
  • Dr Jürgen Werani, Schuh & Co. Komplexitätsmanagement AG, St. Gallen, Switzerland
    Formerly Executive Director of Pfizer Deutschland, today member of the executive board of Schuh & Co.
  • Jörg Zimmermann, Vetter Pharma-Fertigung GmbH & Co. KG, Ravensburg, Germany
    Mr Zimmermann is Director Process Development and Implementation.

Exhibitors 2012

Here you find the current status of the Exhibitor List with Floor Plan.

Pharma Congress 2012:

Download the complete PROGRAMME

Download the detailed AGENDA
 

 

Pharma Congress 2012: Call for Papers

Become part of the Congress – as a Speaker

Logo Concept.